What is TuHURA Biosciences, Inc.'s asset turnover?

TuHURA Biosciences, Inc. (HURA) reported asset turnover of 0× in Q1 2026.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

TuHURA Biosciences, Inc. HURA Asset turnover

Asset turnover at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Inhibrx Biosciences, Inc.INBX

0×0.0×

ImmunityBio, Inc.IBRX

0.3×+0.2×

Avalo TherapeuticsAVTX

0×-0.1×

Janux TherapeuticsJANX

0×0.0×

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Calculated from TuHURA Biosciences, Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s asset turnover?: TuHURA Biosciences, Inc. (HURA) reported asset turnover of 0× in Q1 2026.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.